Literature DB >> 28285193

Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects.

Jaya Arya1, Sebastien Henry1, Haripriya Kalluri1, Devin V McAllister1, Winston P Pewin1, Mark R Prausnitz2.   

Abstract

To support translation of microneedle patches from pre-clinical development into clinical trials, this study examined the effect of microneedle patch application on local skin reactions, reliability of use and acceptability to patients. Placebo patches containing dissolving microneedles were administered to fifteen human participants. Microneedle patches were well tolerated in the skin with no pain or swelling and only mild erythema localized to the site of patch administration that resolved fully within seven days. Microneedle patches could be administered by hand without the need of an applicator and delivery efficiencies were similar for investigator-administration and self-administration. Microneedle patch administration was not considered painful and the large majority of subjects were somewhat or fully confident that they self-administered patches correctly. Microneedle patches were overwhelmingly preferred over conventional needle and syringe injection. Altogether, these results demonstrate that dissolving microneedle patches were well tolerated, easily usable and strongly accepted by human subjects, which will facilitate further clinical translation of this technology.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acceptability; Dissolvable microneedle patch; Drug delivery; Human study; Skin vaccination; Tolerability; Usability

Mesh:

Year:  2017        PMID: 28285193      PMCID: PMC5382793          DOI: 10.1016/j.biomaterials.2017.02.040

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

Review 1.  Microneedle technologies for (trans)dermal drug and vaccine delivery.

Authors:  Koen van der Maaden; Wim Jiskoot; Joke Bouwstra
Journal:  J Control Release       Date:  2012-02-04       Impact factor: 9.776

2.  Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis.

Authors:  Peter E Daddona; James A Matriano; Jaap Mandema; Yuh-Fun Maa
Journal:  Pharm Res       Date:  2010-06-22       Impact factor: 4.200

Review 3.  Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success.

Authors:  Ester Caffarel-Salvador; Ryan F Donnelly
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.

Authors:  Elena V Vassilieva; Haripriya Kalluri; Devin McAllister; Misha T Taherbhai; E Stein Esser; Winston P Pewin; Joanna A Pulit-Penaloza; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

5.  Microneedles in clinical practice--an exploratory study into the opinions of healthcare professionals and the public.

Authors:  James C Birchall; Rachel Clemo; Alexander Anstey; Dai N John
Journal:  Pharm Res       Date:  2010-03-18       Impact factor: 4.200

6.  Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.

Authors:  Sachiko Hirobe; Hiroaki Azukizawa; Takaaki Hanafusa; Kazuhiko Matsuo; Ying-Shu Quan; Fumio Kamiyama; Ichiro Katayama; Naoki Okada; Shinsaku Nakagawa
Journal:  Biomaterials       Date:  2015-04-24       Impact factor: 12.479

Review 7.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Dissolving polymer microneedle patches for influenza vaccination.

Authors:  Sean P Sullivan; Dimitrios G Koutsonanos; Maria Del Pilar Martin; Jeong Woo Lee; Vladimir Zarnitsyn; Seong-O Choi; Niren Murthy; Richard W Compans; Ioanna Skountzou; Mark R Prausnitz
Journal:  Nat Med       Date:  2010-07-18       Impact factor: 53.440

9.  Effect of microneedle design on pain in human volunteers.

Authors:  Harvinder S Gill; Donald D Denson; Brett A Burris; Mark R Prausnitz
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

Review 10.  Microneedle patches for vaccination in developing countries.

Authors:  Jaya Arya; Mark R Prausnitz
Journal:  J Control Release       Date:  2015-11-18       Impact factor: 9.776

View more
  43 in total

1.  Engineering Biomaterials to Direct Innate Immunity.

Authors:  R S Oakes; E Froimchuk; C M Jewell
Journal:  Adv Ther (Weinh)       Date:  2019-02-27

2.  Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.

Authors:  Archana V Boopathy; Anasuya Mandal; Daniel W Kulp; Sergey Menis; Nitasha R Bennett; Hannah C Watkins; Wade Wang; Jacob T Martin; Nikki T Thai; Yanpu He; William R Schief; Paula T Hammond; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

3.  Sampling interstitial fluid from human skin using a microneedle patch.

Authors:  Pradnya P Samant; Megan M Niedzwiecki; Nicholas Raviele; Vilinh Tran; Juan Mena-Lapaix; Douglas I Walker; Eric I Felner; Dean P Jones; Gary W Miller; Mark R Prausnitz
Journal:  Sci Transl Med       Date:  2020-11-25       Impact factor: 17.956

4.  Mechanisms of sampling interstitial fluid from skin using a microneedle patch.

Authors:  Pradnya P Samant; Mark R Prausnitz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

5.  Microneedle Array Patch (MAP) Consisting of Crosslinked Hyaluronic Acid Nanoparticles for Processability and Sustained Release.

Authors:  Dae-Sung Kim; Jun-Tae Choi; Cheong Bi Kim; Yu-Ra Shin; Pil-Gu Park; Hyemi Kim; Jae Myun Lee; Jung-Hwan Park
Journal:  Pharm Res       Date:  2020-02-07       Impact factor: 4.200

Review 6.  An update on coating/manufacturing techniques of microneedles.

Authors:  Tamara N Tarbox; Alan B Watts; Zhengrong Cui; Robert O Williams
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

7.  Plasmonic Paper Microneedle Patch for On-Patch Detection of Molecules in Dermal Interstitial Fluid.

Authors:  Chandana Kolluru; Rohit Gupta; Qisheng Jiang; Mikayla Williams; Hamed Gholami Derami; Sisi Cao; Richard K Noel; Srikanth Singamaneni; Mark R Prausnitz
Journal:  ACS Sens       Date:  2019-05-22       Impact factor: 7.711

Review 8.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

Review 9.  Improving Vaccine and Immunotherapy Design Using Biomaterials.

Authors:  Michelle L Bookstaver; Shannon J Tsai; Jonathan S Bromberg; Christopher M Jewell
Journal:  Trends Immunol       Date:  2017-12-14       Impact factor: 16.687

10.  Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.

Authors:  Stephen C Balmert; Cara Donahue Carey; Gabriel D Falo; Shiv K Sethi; Geza Erdos; Emrullah Korkmaz; Louis D Falo
Journal:  J Control Release       Date:  2019-11-19       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.